Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Retinal progenitor cells for treatment of retinitis pigmentosa

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Retinitis pigmentosa (RP) is a severe form of blindness that runs in families with an incidence of 1:4000. A team at UC Irvine, is using cells called retinal progenitor cells…

Continue ReadingRetinal progenitor cells for treatment of retinitis pigmentosa

Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingHypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes

Regenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes.

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingRegenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes.

TY1 and Semaglutide to Treat Cardiometabolic HFpEF

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingTY1 and Semaglutide to Treat Cardiometabolic HFpEF

Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

Stem Cell-Based Cartilage Tissue Regeneration

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingStem Cell-Based Cartilage Tissue Regeneration

Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingAutologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence

Placental Derived Natural Killer Cells to Target Solid Tumor Cancer Stem Cells (CSC)

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Translational Candidate Placental-derived stem cells becoming a unique NK-like cell Area of Impact solid tissue cancers Mechanism of Action These expanded cells share many characteristics as NK cells but appear…

Continue ReadingPlacental Derived Natural Killer Cells to Target Solid Tumor Cancer Stem Cells (CSC)

Development of a humanized mouse model for testing anti-HIV HSPC gene therapy strategies in HIV-1 infected mice.

  • Post author:
  • Post published:September 25, 2026
  • Post category:

Continue ReadingDevelopment of a humanized mouse model for testing anti-HIV HSPC gene therapy strategies in HIV-1 infected mice.
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us